Nanotherapeutics in cancer vaccination and challenges /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Rahman, Mahfoozur
Formato: eBook
Idioma:Inglés
Publicado: London : Academic Press, 2022.
Temas:
Cancer > Vaccination.
Nanomedicine.
Cancer vaccines.
Nanoparticles.
Cancer Vaccines
Nanoparticles
Neoplasms > therapy
Nanomedicine
Nanom�edecine.
Vaccins anticanc�ereux.
Nanoparticules.
Cancer > Vaccination
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • Nanotherapeutics in Cancer Vaccination and Challenges
  • Nanotherapeutics in Cancer Vaccination and Challenges
  • Copyright
  • Dedication
  • Contents
  • List of contributors
  • Preface
  • Acknowledgments
  • 1
  • Cancer vaccines: past, present, and future
  • 1. Introduction
  • 2. Cancer vaccines and their applications
  • 3. Smart carriers in cancer vaccine delivery
  • 3.1 Nanoparticles
  • 3.2 Liposomes
  • 3.3 Nanoemulsions
  • 3.4 Magnetic nanoparticles
  • 3.5 Niosomes
  • 3.6 Bilosomes
  • 3.7 Archeosomes
  • 3.8 Microspheres
  • 3.9 Viral nanovectors
  • 3.10 Immuno potentiating virosomal carriers
  • 4. Key challenges: formulation challenges and regulatory hurdles
  • 5. Conclusion and future perspectives
  • References
  • 2
  • Inorganic nanoparticulate carriers in management of cancer: theranostics and toxicity apprehension
  • 1. Introduction
  • 2. Inorganic nanoparticles
  • 2.1 QD
  • 2.2 Gold nanoparticles
  • 2.3 Magnetic nanoparticles
  • 2.4 Mesoporous silica nanoparticles (MSNPs)
  • 2.5 Aluminum-based nanoparticle
  • 2.6 Calcium-based nanoparticle
  • 2.7 Carbon nanoparticle
  • 3. Advantages of inorganic nanoparticle
  • 4. Application of inorganic nanoparticles in cancer treatment
  • 4.1 Toxicity
  • 5. Conclusion
  • References
  • 3
  • Recent developments in cancer vaccines: where are we?
  • 1. Introduction
  • 2. Vaccines and their mechanism of action
  • 3. Classification of cancer vaccine
  • 3.1 Prophylactic vaccine
  • 3.2 Autologous tumor cell vaccine
  • 3.3 Allogenic tumor cell vaccine
  • 3.4 Dendritic cell (DC) vaccine
  • 3.5 Protein/peptide-based vaccine
  • 3.6 Genetic vaccine
  • 3.6.1 DNA vaccine
  • 3.7 RNA vaccine
  • 4. The fundamental mechanism of antitumor immunity
  • 5. Cancer and its types
  • 5.1 Breast cancer
  • 5.2 Liver cancer
  • 5.3 Lung cancer
  • 5.4 Bladder cancer
  • 5.5 Colorectal cancer
  • 5.6 Leukemia
  • 5.7 Prostate cancer
  • 5.8 Pancreatic cancer
  • 5.9 Melanoma
  • 5.10 Kidney cancer
  • 6. Present cancer treatments
  • 6.1 Surgery
  • 6.2 Radiation therapy
  • 6.3 Chemotherapy
  • 6.4 Targeted therapy
  • 6.4.1 Immunotherapy
  • 6.5 Hormone therapy
  • 6.6 Stem cell therapy
  • 7. Significance of the development of cancer vaccine
  • 8. Known or possible targets for the development of cancer vaccines
  • 9. Current status on the development of cancer vaccines
  • 9.1 Preclinical studies on vaccine developments
  • 9.2 Clinical studies on vaccine developments
  • 10. Future perspectives of cancer vaccines
  • 11. Conclusion
  • 12. Conflict of interest
  • Acknowledgments
  • References
  • 4
  • Application of nanotechnology assisted devices in cancer treatment
  • 1. Introduction
  • 2. Nanotechnology in cancer
  • 3. Devices based on nanotechnology
  • 4. Nanotechnology and medical devices
  • 5. Emerging medical devices using nanotechnology for cancer therapy
  • 6. Challenges and regulations
  • 7. Advantages and disadvantages of nanotechnology in cancer

Ejemplares similares